Monument Therapeutics
Monument Therapeutics is a psychiatric drug developer for schizophrenia treatment founded in 2019 by Jenny Barnett .
2
Funding Rounds
$2.4m
Money raised
Overview
Monument Therapeutics is a psychiatric drug developer for schizophrenia treatment founded in 2019 by Jenny Barnett .
-
Website:
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Monument Therapeutics has raised a total of $2.4m in funding over 2 rounds.
Key Insights:
- Monument Therapeutics Seed Round, February 2025: $1.1m
- Monument Therapeutics Seed Round, October 2024: $1.3m
Monument Therapeutics Seed Round, February 2025
$1.1m
Monument Therapeutics Seed Round, October 2024
$1.3m
Industries
Monument Therapeutics is active in the following industries: